The American pharmaceutical giant Pfizer wants to further reduce global inequalities in the field of health.

On Tuesday, it announced it would sell nearly 500 of its vaccines and drugs at cost to poorer countries.

Last May, the group indicated, as part of an initiative announced at the Davos Economic Forum, that it would supply 23 of its patented vaccines and medicines available in the United States and the European Union to 45 poor countries. - the equivalent of 1.2 billion people.

"Pfizer will now expand its offering under the agreement to include off-patent products, bringing the total of products offered from 23 to approximately 500," the company said in a statement.

These are all products for which Pfizer has worldwide rights, she said.

Selling at cost means that only manufacturing costs and transport expenses will be charged in the countries concerned.


Today we expanded our commitment to An Accord for a Healthier World to now enable access to ~500 Pfizer patented and off-patent medicines and vaccines on a not-for-profit basis to 45 lower-income countries.

Learn More: https://t.co/FPgWPzdiGB #WEF23 #HealthEquity pic.twitter.com/pHzyFJj9f0

— Pfizer Inc. (@pfizer) January 17, 2023

Access to this content has been blocked to respect your choice of consent

By clicking on "

I ACCEPT

", you accept the deposit of cookies by external services and will thus have access to the content of our partners

I ACCEPT

And to better remunerate 20 Minutes, do not hesitate to accept all cookies, even for one day only, via our "I accept for today" button in the banner below.

More information on the Cookie Management Policy page.




“A longer and healthier life”

Among the drugs and vaccines concerned are products "treating or preventing many of the greatest threats of infectious and non-communicable diseases facing low-income countries today", such as antibiotics or chemotherapy, added the business.



"We believe that this expansion of our product offering, combined with continued efforts to help address the barriers that limit or prevent access, will help us realize and even accelerate our vision of a world in which the world has access to the medicines and vaccines needed for a longer and healthier life,” Pfizer CEO Albert Bourla said in the statement.

As Pfizer launches other drugs and vaccines, they will also be included in the agreement.

Justice

Covid-19: The possible side effects of the Pfizer vaccine in court in Marseille

Health

Bronchiolitis: Moderna announces positive interim results for a vaccine

  • Health

  • Pfizer-BioNTech

  • UNITED STATES

  • Drug

  • Vaccine